按性传播感染史及种族和民族划分的医疗补助参保孕妇产前梅毒筛查
该研究利用肯塔基、路易斯安那和南卡罗来纳三州2017至2021年医疗补助索赔数据,分析孕妇产前梅毒筛查与性传播感染史及患者特征的关系。结果显示有性传播感染史者筛查几率更高(调整比值比1.09-1.37),但早期筛查率仍低,黑人女性早孕期筛查几率低于白人女性(调整比值比0.85)。
要点
- 有性传播感染史孕妇的产前梅毒筛查率高于无性传播感染史者(78.1%-91.1% vs 62.8%-85.1%)
- 仅靠医疗补助索赔数据会遗漏性传播感染史,州A中53.0%的性传播感染史未被检出
- 黑人女性早孕期筛查几率低于白人女性(调整比值比0.85),但晚孕期筛查几率更高(调整比值比1.23-2.03)
核心结论
- 既往性传播感染和孕前持续医疗补助参保与更高的梅毒筛查率相关,但仅用医疗补助索赔数据不能完全反映患者的性传播感染史。
- 总体筛查率低于所有女性均应接受产前筛查的预期,晚孕期筛查率尤其低。
- 非西班牙裔黑人女性早孕期筛查几率低于非西班牙裔白人女性,尽管其梅毒风险更高。
研究设计与样本
- 利用肯塔基、路易斯安那和南卡罗来纳三州2017至2021年分娩女性的医疗补助索赔数据。
- 在各州内分析产前梅毒筛查的对数几率与母亲健康史、人口学因素及医疗补助参保史的关系。
- 患者史通过医疗补助索赔数据4年回顾期确定;州A使用性传播感染监测数据以改善性传播感染史。
主要发现
- 无近期性传播感染史分娩者的产前梅毒筛查率为62.8%至85.1%,有性传播感染史者为78.1%至91.1%。
- 有性传播感染史的分娩者接受任何时间筛查的调整比值比为1.09至1.37。
- 整个早孕期持续医疗补助参保的分娩者任何时间筛查的调整比值比为2.45至3.15。
- 有性传播感染史的分娩者中,仅53.6%至63.6%接受早孕期筛查;仅限有性传播感染史且早孕期全程医疗补助参保者时,该比例为55.0%至69.5%。
- 有性传播感染史的分娩者晚孕期筛查率为20.3%至55.8%;黑人女性早孕期筛查调整比值比0.85(所有州),晚孕期筛查调整比值比1.23至2.03。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Congenital syphilis can cause severe morbidity, including miscarriage and stillbirth, and rates are increasing rapidly within the United States. However, congenital syphilis can be prevented with early detection and treatment of syphilis during pregnancy. Current screening recommendations propose that all women should be screened early in pregnancy, whereas women with elevated risks for congenital syphilis should be screened again later in pregnancy. The rapid increase in congenital syphilis rates suggests that there are still gaps in prenatal syphilis screening. OBJECTIVE: This study aimed to examine associations between the odds of prenatal syphilis screening and sexually transmitted infection history or other patient characteristics across 3 states with elevated rates of congenital syphilis. STUDY DESIGN: We used the Medicaid claims data from Kentucky, Louisiana, and South Carolina for women with deliveries between 2017 and 2021. Within each state, we examined the log-odds of prenatal syphilis screening as a function of the mother's health history, demographic factors, and Medicaid enrollment history. Patient history was established using a 4-year lookback period of the Medicaid claims data; in state A, sexually transmitted infection surveillance data were used to improve the sexually transmitted infection history. RESULTS: The prenatal syphilis screening rates varied by state, ranging from 62.8% to 85.1% of deliveries to women without a recent history of sexually transmitted infections and from 78.1% to 91.1% of deliveries to women with a previous sexually transmitted infection. For the main outcome of syphilis screening at any time during pregnancy, deliveries associated with previous sexually transmitted infections had 1.09 to 1.37 times higher adjusted odds ratios of undergoing screening. Deliveries to women with continuous Medicaid coverage throughout the first trimester also had higher odds of syphilis screening at any time (adjusted odds ratio, 2.45-3.15). Among deliveries to women with a previous sexually transmitted infection, only 53.6% to 63.6% underwent first-trimester screening and this rate was still just 55.0% to 69.5% when considering only deliveries to women with a previous sexually transmitted infection and full first-trimester Medicaid coverage. Fewer delivering women underwent third-trimester screening (20.3%-55.8% of women with previous sexually transmitted infection). Compared with deliveries to White women, deliveries to Black women had lower odds of first-trimester screening (adjusted odds ratio, 0.85 in all states) but higher odds of third-trimester screening (adjusted odds ratio, 1.23-2.03), potentially impacting maternal and birth outcomes. For state A, linkage to surveillance data doubled the rate of detection of a previous sexually transmitted infection because 53.0% of deliveries by women with a previous sexually transmitted infection would not have had sexually transmitted infection history detected using Medicaid claims alone. CONCLUSION: A previous sexually transmitted infection and continuous preconception Medicaid enrollment were associated with higher rates of syphilis screening, but Medicaid claims alone do not fully capture the sexually transmitted infection history of patients. The overall screening rates were lower than would be expected given that all women should undergo prenatal screening, but the rates in the third trimester were particularly low. Of note, there are gaps in early screening for non-Hispanic Black women who had lower odds of first-trimester screening when compared with non-Hispanic White women despite being at elevated risk for syphilis.
引用
- Hammerslag LR, Campbell-Baier RE, Otter CA, et al. Prenatal syphilis screening among pregnant Medicaid enrollees by sexually transmitted infection history as well as race and ethnicity. Am J Obstet Gynecol MFM. 2023. PMID: 36933802. doi:10.1016/j.ajogmf.2023.100937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。